Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.

Further Reading

New study provides reassuring information about safety of osteoporosis drug

New study provides reassuring information about safety of osteoporosis drug

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

EuroPrevent 2017 to explore innovative ideas in preventive cardiology

EuroPrevent 2017 to explore innovative ideas in preventive cardiology

Scientists reveal new mRNA method to deliver safe, cost-effective therapeutic antibodies

Scientists reveal new mRNA method to deliver safe, cost-effective therapeutic antibodies

Study shows new drug as promising treatment option for difficult-to-treat rheumatoid arthritis patients

Study shows new drug as promising treatment option for difficult-to-treat rheumatoid arthritis patients

New anti-cocaine monoclonal antibody moves forward towards clinical studies in humans

New anti-cocaine monoclonal antibody moves forward towards clinical studies in humans

Scientists propose potential new treatment for Gaucher disease

Scientists propose potential new treatment for Gaucher disease

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Study to investigate effectiveness of novel combination treatment for eradicating HIV

Study to investigate effectiveness of novel combination treatment for eradicating HIV

New immunotherapy active against mucosal melanoma and improves survival for bladder cancer patients

New immunotherapy active against mucosal melanoma and improves survival for bladder cancer patients

New biomarker helps better predict survival after surgical removal of colorectal metastases

New biomarker helps better predict survival after surgical removal of colorectal metastases

Biosimilars create chances to improve sustainability and affordability of cancer treatment

Biosimilars create chances to improve sustainability and affordability of cancer treatment

UCLA-led research finds promising results for more personalized head and neck cancer treatment

UCLA-led research finds promising results for more personalized head and neck cancer treatment

TSRI scientists identify microbial natural products as abundant sources of potent anticancer drugs

TSRI scientists identify microbial natural products as abundant sources of potent anticancer drugs

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

DuPont research project aims to enable global access for protein-based biologic medications

DuPont research project aims to enable global access for protein-based biologic medications

Treatment with biosimilar drug improves progression-free survival in breast cancer patients

Treatment with biosimilar drug improves progression-free survival in breast cancer patients